Infectious diseases and vaccines Archives - Page 4 of 11

A novel approach to estimate the local population denominator to calculate disease incidence for hospital-based health events in England

Authors: J Campling, E Begier, A Vyse, C Hyams, D Heaton, J Southern, A Finn, H Madhava, B D Gessner, G Ellsbury Published: Epidemiology and infection, 2022 View publication Abstract While incidence...

Cost-effectiveness analysis of simeprevir in combination with peginterferon and ribavirin for treatment-naïve chronic hepatitis C genotype 1 patients in Japan

Authors: H Kuwabara, K Westerhout, M Treur, K Cerri, J Mahlich, H Yatsuhashi Published: Journal of Medical Economics, 2015 View publication Aim Simeprevir (SMV), a protease inhibitor, recently became available for the...

Long-term assessment of healthcare utilization 5 years after respiratory syncytial virus infection in US infants

Authors: E A F Simões, V Chirikov, M Botteman, Y Kwon, A Kuznik Published: Journal of Infectious Diseases, 2020 View publication Background Respiratory syncytial virus (RSV) is the primary cause of respiratory...

Feasibility of weekly HIV drug delivery to enhance drug localization in lymphoid tissues based on pharmacokinetic models of lipid-associated indinavir

Authors: S J Snedecor, S M Sullivan, R J Y Ho Published: Pharmaceutical Research, 2006 View publication Purpose Compare the simulated pharmacokinetics of lipid-associated and soluble indinavir (IDV) to determine the potential...

Patient-reported outcomes in individuals with hepatitis C virus infection treated with elbasvir/grazoprevir

Authors: X Ng, C Nwankwo, J M Arduino, S Corman, K E Lasch, J M Lustrino, S Patel, H L Platt, J Qiu, J Sperl Published: Patient preference and adherence, 2018 View...

Patient characteristics and risk factors in invasive mold infections: comparison from a systematic review and database analysis

Authors: A H Sung, S Martin, B Phan, M Benigno, J Stephens, R Chambers, J A Aram Published: ClinicoEconomics and outcomes research : CEOR, 2021 View publication Introduction Diagnosis and treatment of...

Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus

Authors: D A Patel, A F Shorr, J Chastre, M Niederman, A Simor, J M Stephens, C Charbonneau, X Gao, D Nathwani Published: Critical Care, 2014 View publication Introduction We compared the...

Review of the impact of NNRTI-based HIV treatment regimens on patient-reported disease burden

Authors: K N Simpson, K A Hanson, G Harding, S Haider, M Tawadrous, A Khachatryan, C L Pashos, A W Wu Published: AIDS Care – Psychological and Socio-Medical Aspects of AIDS/HIV, 2014...

Systematic literature review of the disease burden and vaccination of pneumococcal disease among adults in select Asia-Pacific areas

Authors: T Tantawichien, L Y Hsu, O Zaidi, M Bernauer, F Du, E Yamada, J O Kim, I Sukarom Published: Expert Review of Vaccines, 2022 View publication Introduction Pneumococcal diseases are common...

News